Clinical Trials Directory

Trials / Completed

CompletedNCT03653936

Neuro-ocular Baselines in a Sports Setting

Neuro-ocular Baselines in a Sports Setting: Feasibility Study for Head and Intraocular Trauma Test (HITT) Device for Potential Detection of Brain Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
Rebiscan, Inc. · Industry
Sex
All
Age
11 Years – 21 Years
Healthy volunteers
Accepted

Summary

Rebion (Rebiscan, Inc) has developed a noninvasive, handheld device that uses retinal birefringence scanning (RBS) to rapidly assess eye fixation and retinal integrity in adults and children. The proprietary technology uses a scanned annulus of polarized laser light to create a signature that confirms central fixation within seconds. The project described herein aims to provide accurate assessment of brain dysfunction in TBI (Traumatic Brain Injury) patients through the use of the developed device, which is called the Head and Intraocular Trauma Test (HITT) device.

Conditions

Interventions

TypeNameDescription
DEVICEHITT deviceRebion has developed a noninvasive, handheld device that uses retinal polarization scanning (RPS) to rapidly assess eye fixation and retinal integrity in adults and children. RPS can automatically detect the fixation of the human eye with proprietary technology that uses a scanned annulus of polarized laser light to create a signature that confirms central fixation within seconds. RPS requires no calibration or imaging, and eye movement recordings are not required. The HITT device is a repurposed Pediatric Vision Scanner (PVS), Rebion's first commercial product which has passed all applicable safety and performance standards.

Timeline

Start date
2018-04-01
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2018-08-31
Last updated
2019-04-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03653936. Inclusion in this directory is not an endorsement.

Neuro-ocular Baselines in a Sports Setting (NCT03653936) · Clinical Trials Directory